Cite
Nair P, Aiello LP, Gardner TW, et al. Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop. Invest Ophthalmol Vis Sci. 2016;57(13):5127-5142doi: 10.1167/iovs.16-20356.
Nair, P., Aiello, L. P., Gardner, T. W., Jampol, L. M., & Ferris, F. L. (2016). Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop. Investigative ophthalmology & visual science, 57(13), 5127-5142. https://doi.org/10.1167/iovs.16-20356
Nair, Prashant, et al. "Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop." Investigative ophthalmology & visual science vol. 57,13 (2016): 5127-5142. doi: https://doi.org/10.1167/iovs.16-20356
Nair P, Aiello LP, Gardner TW, Jampol LM, Ferris FL. Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop. Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5127-5142. doi: 10.1167/iovs.16-20356. PMID: 27699406; PMCID: PMC6016432.
Copy
Download .nbib